Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New class of topo I inhibitors designed for oral administration

May 9, 1997

Natural cancer immunotherapeutic discovered by Yonsei University researchers

May 9, 1997

Novel EGF receptor TK inhibitor described by Mitsubishi

May 9, 1997

BM-92.0700: a promising anticancer clinical candidate

May 9, 1997

ONYX-015 demonstrates in vitro and in vivo efficacy

May 9, 1997

Preclinical data for ZD-1839, an EGF tyrosine kinase inhibitor

May 9, 1997

Cinchonine shown to reverse multidrug resistance

May 9, 1997

Preclinical and preliminary clinical data reported for LU-103793

May 9, 1997

Alniditan more effective than sumatriptan in animal model of migraine

May 7, 1997

Riboflavin shows promise for migraine prophylaxis

May 7, 1997

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.